Descending necrotizing mediastinitis: key points to reduce the high associated mortality in a consecutive case series
Mediastinum · 2024-03 · 8 · 8-8
DOI: 10.21037/med-23-32 ↗Kurz gefasst
Fallbericht in der Zeitschrift Mediastinum, 2024-03. Verfasst von María Del Prado Venegas Pizarro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Otorhinolaryngology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
- Sant Pau Biomedical Research Institute-IIB Sant Pau, Barcelona, Spain.
- Thoracic Surgery Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Zitieren
APA
Venegas Pizarro, M. D. P., Martínez Téllez, E., León Vintró, X., Quer Agustí, M., Trujillo-Reyes, J. C., Libreros-Niño, A., Planas Cánovas, G., & Belda-Sanchis, J. (2024). Descending necrotizing mediastinitis: key points to reduce the high associated mortality in a consecutive case series. Mediastinum, 8, 8-8. https://doi.org/10.21037/med-23-32
Vancouver
Venegas Pizarro MDP, Martínez Téllez E, León Vintró X, Quer Agustí M, Trujillo-Reyes JC, Libreros-Niño A, et al. Descending necrotizing mediastinitis: key points to reduce the high associated mortality in a consecutive case series. Mediastinum. 2024;8:8-8. doi:10.21037/med-23-32
BibTeX
@article{VenegasPizarro2024,
author = {Venegas Pizarro, María Del Prado and Martínez Téllez, Elisabeth and León Vintró, Xavier and Quer Agustí, Miquel and Trujillo-Reyes, Juan Carlos and Libreros-Niño, Alejandra and Planas Cánovas, Georgina and Belda-Sanchis, Josep},
title = {Descending necrotizing mediastinitis: key points to reduce the high associated mortality in a consecutive case series},
journal = {Mediastinum},
year = {2024},
volume = {8},
pages = {8--8},
doi = {10.21037/med-23-32}
}
EUVIMED